PMH34 Long-Term Cost-Effectiveness of Atypical Antipsychotics for Schizophrenia in the United States
Jun 1, 2012, 00:00 AM
10.1016/j.jval.2012.03.479
https://www.valueinhealthjournal.com/article/S1098-3015(12)00544-X/fulltext
Section Title :
Mental Health
Section Order :
1266
First Page :
A87
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00544-X&doi=10.1016/j.jval.2012.03.479